key: cord-0872216-azupktup
authors: Islam, Fahadul; Dhawan, Manish; Nafady, Mohamed H.; Emran, Talha Bin; Mitra, Saikat; Choudhary, Om Prakash; Akter, Aklima
title: Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: Mutational impacts, concerns, and the possible solutions
date: 2022-05-07
journal: Ann Med Surg (Lond)
DOI: 10.1016/j.amsu.2022.103737
sha: 25b181aaa218611fa243405443a103c415661e3d
doc_id: 872216
cord_uid: azupktup

Despite many nations' best efforts to contain the so-called COVID-19 pandemic, the emergence of the SARS-CoV-2 Omicron strain (B.1.1.529) has been identified as a serious concern. After more than two years of COVID-19 pandemic and more than a year of worldwide vaccination efforts, the globe will not be free of COVID-19 variants such as Delta and Omicron variants. According to current statistics, the Omicron variant has more than 30 mutations when contrasted to other VOCs such as Alpha (B.1.1.7), Beta (B.1.351), and Delta (B.1.617.2). High numbers of changes, particularly in the spike protein (S-Protein), raise worries about the virus's capacity to resist pre-existing immunity acquired by vaccination or spontaneous infection and antibody-based therapy. The Omicron variant raised international concerns, resuming travel bans and coming up with many questions about its severity, transmissibility, testing, detection, and vaccines efficiency against it. Additionally, inadequate health care infrastructures and many immunocompromised individuals increase the infection susceptibility. The current status of low vaccination rates will play a significant role in omicron spreading and create a fertile ground for producing new variants. As a result, this article emphasizes the mutational changes and their consequences. In addition, the potential preventing measures have been examined in detail.

Multiple variants of SARS-CoV-2 have been identified since the start of the COVID-19 25 pandemic. These variants have been related to a significant increase in fatality rates in several 26 countries [1, 2] . The World Health Organization (WHO) has previously identified five VOCs: 27 Alpha, Beta, Gamma, Delta, and Omicron variants. The emergence of novel SARS-CoV-2 28 variants, notably VOCs like Delta, Beta, and Alpha, has been linked to the rapid increase of critical for the binding between spike proteins and neutralizing antibodies were studied, and it has 90 been postulated that the changes can influence the neutralization capabilities (Table 1 ). In addition, 91 they also looked at how critical antibody-binding mutations such as K417N, T478K, E484A, and 92 N501Y influenced antibody affinity, ACE2 association stability, and the potential of amino acid 93 replacement. The antibody-binding affinity is destabilized by all four alterations [12] . 

The Spike protein in omicron has a mutation 69-70 (identical to Alpha but distinct to Delta).

Because one PCR test, ThermoFisher TaqPath, can identify the deletion of this target gene (also 162 known as S gene dropout or S gene target malfunction), it could be used as an early indicator to 163 distinguish between Omicron and Delta, awaiting sequenced validation. On omicron, it's unclear 164 how well quick antigen tests will work. Several (but not all) assays on the targeted market the 165 nucleocapsid protein rather than the spike protein; therefore, they should continue to operate. which is now underway [66, 67] . It is necessary to create a vaccination that is effective enough to The data supporting this study's findings are available from the corresponding author upon 285 reasonable request.

The authors declare that they have no conflicts of interest. 

Multiplex qPCR discriminates variants of concern to enhance 512 global surveillance of SARS-CoV-2

Increased risk of SARS-CoV-2 reinfection associated 516 with emergence of the Omicron variant in South Africa

Scientists detect a new variant in South Africa with

New COVID-19 variant

Dutch: Some of the 61 COVID cases from South Africa flights are new variants

Impact 531 of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or 532 vaccinated individuals

What we know about the Omicron variant | UNICEF

Covid-19 Vaccine Effectiveness against the 541 Omicron (B.1.1.529) Variant

SARS-CoV-2 existence in sewage and wastewater: A global public 556 health concern?

Omicron: A failure to act with a global focus will continue the proliferation of new 559 variants of covid-19

The Mu strain: The last but not least circulating 561 variant of interest' potentially affecting the COVID-19 pandemic

Covid-19: Unmasking emerging sars-cov-2 variants, 564 vaccines and therapeutic strategies

The emergence of new SARS-CoV-2 variant (Omicron) and increasing calls for COVID-19 vaccine boosters-The debate continues

SARS-CoV-2 570 vaccines: A critical perspective through efficacy data and barriers to herd immunity

Comparing COVID-573 19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and 574 variants of concern: a narrative review

Malnutrition and Dietary Habits Alter the 577

Immune System Which May Consequently Influence SARS-CoV-2 Virulence: A Review

Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 581 fatty acids: could they help against COVID-19?

CoV-2 variant: What we know and what we don't

SARS-CoV-587 2 and its variants of concern including Omicron: A never ending pandemic